Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Persoonlijke factoren en ernst ongeval bepalen gevolgen licht hersenletsel
jun 2017